Baumgart DC et al. |
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up. |
2006 |
Am. J. Gastroenterol. |
pmid:16573777
|
Fellermann K et al. |
Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). |
1998 |
Am. J. Gastroenterol. |
pmid:9772045
|
Nara M et al. |
Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3. |
2010 |
Am. J. Hematol. |
pmid:20568249
|
Lekakis LJ et al. |
BK virus nephropathy after allogeneic stem cell transplantation: a case report and literature review. |
2009 |
Am. J. Hematol. |
pmid:19208419
|
Hammerstrom AE et al. |
Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation. |
2013 |
Am. J. Hematol. |
pmid:23460378
|
Abdel-Azim H et al. |
Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection. |
2015 |
Am. J. Hematol. |
pmid:26242764
|
Uehara T et al. |
Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection. |
2004 |
Am. J. Hematol. |
pmid:15282671
|
Nakamae H et al. |
Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation. |
2006 |
Am. J. Hematol. |
pmid:16755559
|
Bolaños-Meade J et al. |
Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung. |
2005 |
Am. J. Hematol. |
pmid:15929116
|
Ninan MJ and Datta YH |
Post-transplant lymphoproliferative disorder presenting as multiple myeloma. |
2010 |
Am. J. Hematol. |
pmid:20578201
|
Mach-Pascual S et al. |
Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy. |
1996 |
Am. J. Hematol. |
pmid:8701950
|
Uehara T et al. |
A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT. |
2002 |
Am. J. Hematol. |
pmid:12221672
|
Cohen DL et al. |
Pulse wave analysis to assess vascular compliance changes in stable renal transplant recipients. |
2004 |
Am. J. Hypertens. |
pmid:15001192
|
Zhang W and Victor RG |
Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension. |
2000 |
Am. J. Hypertens. |
pmid:10981550
|
Taler SJ et al. |
Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy. |
1995 |
Am. J. Hypertens. |
pmid:7544983
|
Choudhry S et al. |
Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. |
2009 |
Am. J. Kidney Dis. |
pmid:19268410
|
Haas M et al. |
Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. |
1999 |
Am. J. Kidney Dis. |
pmid:10401019
|
Hricik DE |
Safety and efficacy of TOR inhibitors and other immunosuppressive regimens in African-American renal transplant recipients. |
2001 |
Am. J. Kidney Dis. |
pmid:11583939
|
Pescovitz MD and Govani M |
Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients. |
2001 |
Am. J. Kidney Dis. |
pmid:11583940
|
Asif A et al. |
Peritoneoscopic placement of peritoneal dialysis catheter and bowel perforation: experience of an interventional nephrology program. |
2003 |
Am. J. Kidney Dis. |
pmid:14655200
|